{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:07:13Z","timestamp":1760044033803},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T00:00:00Z","timestamp":1362614400000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology International"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:p>Adult <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\u2010cell leukemia\/lymphoma (<jats:styled-content style=\"fixed-case\">ATLL<\/jats:styled-content>) is a peripheral <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\u2010cell neoplasm caused by human <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\u2010cell lymphotropic virus type <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">HTLV<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>). The neoplastic cells are highly pleomorphic and are usually <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4+ and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8\u2212 phenotypically. We reported the case of a 46\u2010year\u2010old woman presenting with fever, abdominal distention, lymphadenopathy, leukocytosis and hypercalcemia. Nodal biopsy showed diffuse infiltration by monomorphic small to medium\u2010sized atypical lymphocytes expressing <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>3, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>25, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>30 and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>99, but not <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>1a, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>34, terminal deoxynucleotidyl transferase or <jats:styled-content style=\"fixed-case\">ALK<\/jats:styled-content>. An initial diagnosis of <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\u2010lymphoblastic leukemia\/lymphoma was made based on cytomorphology, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4 and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8 double negativity, and the expression of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>99. The diagnosis was later revised to <jats:styled-content style=\"fixed-case\">ATLL<\/jats:styled-content> based on the positive serology study for anti\u2010<jats:styled-content style=\"fixed-case\">HTLV I<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">II<\/jats:styled-content> antibody and confirmation by the clonal integration of <jats:styled-content style=\"fixed-case\">HTLV<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">I<\/jats:styled-content> proviral <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> into the tumor tissues by Southern blotting analysis. The patient had a stage <jats:styled-content style=\"fixed-case\">IVB<\/jats:styled-content> disease and died of septic shock after 2 courses of chemotherapy 3 months after diagnosis. Immunohistochemical staining for <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>99 in archival <jats:styled-content style=\"fixed-case\">ATLL<\/jats:styled-content> tissues showed a positive rate of 67% (4 of 6 tumors). Our case showed that <jats:styled-content style=\"fixed-case\">ATLL<\/jats:styled-content> with atypical morphology and immunophenotype in <jats:styled-content style=\"fixed-case\">HTLV<\/jats:styled-content> non\u2010endemic areas might pose a diagnostic challenge and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>99 expression is frequent in <jats:styled-content style=\"fixed-case\">ATLL<\/jats:styled-content>.<\/jats:p>","DOI":"10.1111\/pin.12040","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T08:57:00Z","timestamp":1362646620000},"page":"132-137","source":"Crossref","is-referenced-by-count":7,"title":["<scp>CD<\/scp>4 and <scp>CD<\/scp>8 double\u2010negative adult <scp>T<\/scp>\u2010cell leukemia\/lymphoma with monomorphic cells expressing <scp>CD<\/scp>99: A diagnostic challenge in a country non\u2010endemic for human <scp>T<\/scp>\u2010cell leukemia virus"],"prefix":"10.1111","volume":"63","author":[{"given":"Tsung\u2010Hsien","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Pathology Chi\u2010Mei Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung\u2010Chang","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Hemato\u2010Oncology Department of Internal Medicine Chi\u2010Mei Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen\u2010Chuan","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Pathology Chi\u2010Mei Medical Center"},{"name":"Department of Medical Laboratory Science and Biotechnology Chung Hwa University of Medical Technology  Tainan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih\u2010En","family":"Tseng","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology Buddhist Dalin Tzu Chi General Hospital  Chiayi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[{"name":"Division of Hematopathology Tohoku University Graduate School of Medicine  Sendai Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih\u2010Sung","family":"Chuang","sequence":"additional","affiliation":[{"name":"Department of Pathology Chi\u2010Mei Medical Center"},{"name":"Department of Pathology Taipei Medical University  Taipei Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"281","volume-title":"WHO Classification of Tumours of Haemtopoietic and Lymphoid Tissues","author":"Ohshima K","year":"2008"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(03)00401-3"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2005.20.6.952"},{"key":"e_1_2_6_5_1","first-page":"769","article-title":"CD99, keratin, and vimentin staining of sex cord\u2010stromal tumors, normal ovary, and testis","volume":"11","author":"Gordon MD","year":"1998","journal-title":"Mod Pathol"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004280000240"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00129039-200106000-00004","article-title":"CD99 immunoreactivity in ependymoma","volume":"9","author":"Choi YL","year":"2001","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1309\/K1XJ-6CXR-BQQU-V255"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200211000-00005"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12041"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0889-8588(18)30396-4","article-title":"Non\u2010Hodgkin's lymphomas in Asia","volume":"5","author":"Shih LY","year":"1991","journal-title":"Hematol Oncol Clin North Am"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02982654"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2012.01407.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004280050404"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(92)90168-7"},{"key":"e_1_2_6_16_1","first-page":"423","article-title":"Pathoepidemiological features of adult T\u2010cell lymphoma\/leukemia in an endemic area: Kagoshima, Japan","volume":"14","author":"Sato E","year":"1990","journal-title":"Cancer Detect Prev"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood.V64.2.440.440","article-title":"Changes of adult T cell leukemia cell surface antigens at relapse or at exacerbation phase after chemotherapy defined by use of monoclonal antibodies","volume":"64","author":"Yamada Y","year":"1984","journal-title":"Blood"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309059580"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood.V81.4.1032.1032","article-title":"Double\u2010negative (CD4\u2212 CD8\u2212) T cells from adult T\u2010cell leukemia patients also have poor expression of the T\u2010cell receptor alpha beta\/CD3 complex","volume":"81","author":"Suzushima H","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409056289"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06281.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1200\/JCO.1985.3.6.782","article-title":"Adult T cell leukemia with atypical surface phenotypes: clinical correlation","volume":"3","author":"Yamada Y","year":"1985","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830400205"},{"key":"e_1_2_6_24_1","first-page":"167","article-title":"TDT (\u2212), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia\/lymphoma","volume":"5","author":"Terada T","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880077"},{"key":"e_1_2_6_26_1","first-page":"277","article-title":"013 (CD99) positivity in hematologic proliferations correlates with TdT positivity","volume":"10","author":"Robertson PB","year":"1997","journal-title":"Mod Pathol"},{"key":"e_1_2_6_27_1","volume-title":"Flow Cytometry in Neoplastic Hematology. Morphologic\u2010Immunophenotypic Correlation","author":"Gorczyca W","year":"2006"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1309\/QF6N-VAQW-N74H-4JE2"}],"container-title":["Pathology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpin.12040","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pin.12040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T03:07:03Z","timestamp":1697252823000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pin.12040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1111\/pin.12040"],"URL":"https:\/\/doi.org\/10.1111\/pin.12040","archive":["Portico"],"relation":{},"ISSN":["1320-5463","1440-1827"],"issn-type":[{"value":"1320-5463","type":"print"},{"value":"1440-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}